– USA, WA DC – The National Association of Corporate Directors (NACD) is pleased to announce that Dr. Evan Melrose of Austin, TX has become an NACD Board Leadership Fellow, the highest level of credentialing for corporate directors and corporate governance professionals. Dr. Melrose currently serves as a director on the boards of QSpex Technologies (Chairman), Bioventus, and Avanzar Medical. In addition, he serves on the boards of the Texas Lyceum and the Texas Business Hall of Fame Foundation.
As an NACD Fellow, Dr. Melrose has demonstrated his knowledge of the leading trends and practices that define exemplary corporate governance today and has committed to developing professional insights through a sophisticated course of ongoing study.
“I am honored to join this distinguished group of directors who have been recognized for their exemplary board service and who have committed to advancing the highest standards of boardroom leadership,” said Dr. Melrose. “The formal education provided by the NACD Fellowship program complements my experience serving on many public and private boards. Formal certification and NACD Fellowship provide additional resources and a network to ensure that as a board member I can provide the best support to increase value for shareholders and customers in my service as a Director.”
With over 25 years of experience in the Healthcare industry, Dr. Melrose possesses extensive operating, clinical, and investment experience in many aspects of healthcare investments (both public and private), research, clinical practice, education, and health policy. As the Founding Managing Director of Spindletop Capital, Dr. Melrose is providing pivotal expansion capital for healthcare investments from his firm based in Austin. Prior to Spindletop, he was Founding Managing Director of PTV Sciences, a Texas based venture capital firm, and a Director with Burrill & Company, a San Francisco based life science private equity/venture capital firm.
Dr. Melrose is a board certified physician and has held faculty appointments at the UCSF, UPENN, and currently at Baylor College of Medicine. He received his BA from the University of Pennsylvania, received his MD from Indiana University School of Medicine, and an MBA from The Wharton School. He completed post graduate studies at the Tufts Center for the Study of Drug Development, the University of Pennsylvania School of Engineering, Harvard Medical and Law Schools, Stanford Graduate School of Business and is certified as a Public Company Director by Institutional Shareholder Services/UCLA Anderson School of Business.
“We are proud to announce that Evan has joined NACD’s credentialed directors and has taken the next step in the pursuit of boardroom excellence,” said Ken Daly, president and CEO of NACD. “Our fellows help advance the highest standards for those who serve in the boardroom, strengthening our businesses and driving director professionalism. The impact of this program is unmatched and they should be commended for their ongoing commitment to their own professional development.”
NACD’s Fellows serve on boards of some of the largest and most diverse corporations in the world, including NASDAQ OMX- and NYSE-listed companies such as Aetna, AstraZeneca, Dell, The Dow Chemical Group, HealthSouth, INVESCO Ltd., JetBlue, Medtronic, PPG Industries, and UnitedHealth Group.
NACD Fellows represent hundreds of companies and provide a snapshot of the caliber of corporate directors engaged in continuous learning with NACD–the leading organization that identifies, interprets and provides insights and information that boardroom leaders rely upon to apply their wisdom and knowledge and make sound strategic decisions.
ABOUT SPINDLETOP CAPITAL MANAGEMENT
Spindletop Capital, founded in 2011, is a healthcare investment firm focused on providing expansion capital for commercial stage healthcare companies. Based in Austin, Spindletop is managed by an unrivaled team of investment professionals and advisors with deep operating, technical, and transactional experience. Spindletop Capital leverages the organization’s deep experience, broad network and proprietary access to Texas resources to enhance value for management teams and financing syndicates. Spindletop Capital invests nationally across all sectors of healthcare including medical devices, diagnostics, healthcare services, healthcare IT, specialty pharmaceuticals and biotechnology.
The National Association of Corporate Directors (NACD) is the only membership organization focused exclusively on advancing exemplary board leadership. Based on more than 35 years of experience, NACD identifies, interprets, and provides insights and information that corporate board members rely upon to make sound strategic decisions, confidently confront complex business challenges, and enhance shareowner value. With more than 13,000 corporate director members, NACD provides world-class director education, director training, and proprietary research about leading boardroom and corporate governance practices to promote director professionalism and bolster investor confidence. Furthermore, to create more effective and efficient corporate boards, NACD provides independent board evaluations and custom-tailored in-boardroom education and training programs, as well as director-led conferences, forums, and peer-exchange learning opportunities to share ideas about current and emerging issues. Fostering collaboration among directors and governance stakeholders, NACD is shaping the future of board leadership.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.